April 13, 2026 International Good Deeds Day: 115 Countries, Millions of Participants, and One Woman’s Initiative That Sparked a Global Movement of Doing Good
April 13, 2026 SynOx Therapeutics Announces Positive Topline Results from the Phase 3 TANGENT Study, Supporting Emactuzumab as a Differentiated, Next-generation Treatment for Patients with Tenosynovial Giant Cell Tumor (TGCT)
